Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy ANI Pharmaceuticals stock
Learn how to easily invest in ANI Pharmaceuticals stock.
ANI Pharmaceuticals Inc is a drug manufacturers-specialty & generic business based in the US. ANI Pharmaceuticals shares (ANIP) are listed on the NASDAQ and all prices are listed in US Dollars. ANI Pharmaceuticals employs 601 staff and has a trailing 12-month revenue of around $251.3 million.
How to buy shares in ANI Pharmaceuticals
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – ANIP – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
ANI Pharmaceuticals stock price (NASDAQ: ANIP)Use our graph to track the performance of ANIP stocks over time.
ANI Pharmaceuticals shares at a glance
|Latest market close||$31.71|
|52-week range||$22.31 - $60.23|
|50-day moving average||$35.05|
|200-day moving average||$34.63|
|Wall St. target price||$43.25|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-4.66|
Buy ANI Pharmaceuticals shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy ANI Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
ANI Pharmaceuticals price performance over time
|1 week (2022-09-19)||-8.48%|
|1 month (2022-08-26)||-16.55%|
|3 months (2022-06-24)||9.69%|
|6 months (2022-03-25)||13.37%|
|1 year (2021-09-24)||-0.75%|
|2 years (2020-09-25)||16.37%|
|3 years (2019-09-26)||72.71|
|5 years (2017-09-26)||49.77|
Is ANI Pharmaceuticals stock undervalued or overvalued?
Valuing ANI Pharmaceuticals stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of ANI Pharmaceuticals's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
ANI Pharmaceuticals's PEG ratio
ANI Pharmaceuticals's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.06. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into ANI Pharmaceuticals's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
ANI Pharmaceuticals's EBITDA
ANI Pharmaceuticals's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $15 million.
The EBITDA is a measure of a ANI Pharmaceuticals's overall financial performance and is widely used to measure a its profitability.
ANI Pharmaceuticals financials
|Revenue TTM||$251.3 million|
|Gross profit TTM||$117.4 million|
|Return on assets TTM||-3.93%|
|Return on equity TTM||-24.07%|
|Market capitalisation||$552.6 million|
TTM: trailing 12 months
ANI Pharmaceuticals share dividends
We're not expecting ANI Pharmaceuticals to pay a dividend over the next 12 months.
Have ANI Pharmaceuticals's shares ever split?
ANI Pharmaceuticals's shares were split on a 1:6 basis on 17 July 2013. So if you had owned 6 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your ANI Pharmaceuticals shares – just the quantity. However, indirectly, the new 500% higher share price could have impacted the market appetite for ANI Pharmaceuticals shares which in turn could have impacted ANI Pharmaceuticals's share price.
ANI Pharmaceuticals share price volatility
Over the last 12 months, ANI Pharmaceuticals's shares have ranged in value from as little as $22.31 up to $60.2267. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while ANI Pharmaceuticals's is 1.0016. This would suggest that ANI Pharmaceuticals's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
ANI Pharmaceuticals overview
ANI Pharmaceuticals, Inc. , a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract development and manufacturing of pharmaceutical products for other companies. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations. The company was incorporated in 2001 and is headquartered in Baudette, Minnesota. .
ANI Pharmaceuticals in the news
ANI Pharmaceuticals Appoints Krista Davis as Chief Human Resources Officer
Bullish ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) insiders filled their treasuries with US$1.0m worth of stock over last year
ANI Pharmaceuticals to Present at the H.C. Wainwright 24th Annual Global Investment Conference
Frequently asked questionsWhat percentage of ANI Pharmaceuticals is owned by insiders or institutions?
Currently 13.147% of ANI Pharmaceuticals shares are held by insiders and 74.842% by institutions. How many people work for ANI Pharmaceuticals?
Latest data suggests 601 work at ANI Pharmaceuticals. When does the fiscal year end for ANI Pharmaceuticals?
ANI Pharmaceuticals's fiscal year ends in December. Where is ANI Pharmaceuticals based?
ANI Pharmaceuticals's address is: 210 Main Street West, Baudette, MN, United States, 56623 What is ANI Pharmaceuticals's ISIN number?
ANI Pharmaceuticals's international securities identification number is: US00182C1036 What is ANI Pharmaceuticals's CUSIP number?
ANI Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 00182C103
More guides on Finder
How to buy YanGuFang International Group (YGF) stock when it goes public
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
What are the FAANG stocks and how do you invest in them?
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
How to buy Lead Real Estate Co. (LRE) stock when it goes public
Everything we know about the Lead Real Estate Co. IPO, plus information on how to buy in.
How to buy Third Harmonic Bio (THRD) stock
Everything we know about the Third Harmonic Bio IPO, plus information on how to buy in.
How to buy LINKBANCORP (LNKB) stock
Everything we know about the LINKBANCORP IPO, plus information on how to buy in.
Here are the stocks that benefit from inflation, as well as industries to keep an eye on to reduce the impacts of inflation on your portfolio.
Ask an Expert